IceCure Medical (ICCM) Fundamental Analysis: Revenue, Earnings & Valuation

0.88 / 10

Underperform

Fundamental rating is Underperform with a 0.9/10 strength. Profit‑MV and Cash‑UP are modest positives, while Cash‑MV, ROE and asset metrics are weak, indicating limited financial resilience.

Analysis Checks(2/10)

ROA (%)

Value-113.79

Score0/3

Weight14.72%

1M Return-6.12%

Annualized return on equity (%)

Value-188.78

Score0/3

Weight14.07%

1M Return-5.73%

Profit-MV

Value0.68

Score2/3

Weight-13.46%

1M Return3.26%

Cash-UP

Value-0.16

Score2/3

Weight12.27%

1M Return-3.92%

Annualized net profit margin on total assets (%)

Value-113.79

Score0/3

Weight14.72%

1M Return-6.12%

ROE (diluted) (%)

Value-166.36

Score0/3

Weight14.78%

1M Return-5.82%

Asset-MV

Value-0.55

Score0/3

Weight10.78%

1M Return-3.34%

ROE (%)

Value-188.78

Score0/3

Weight14.07%

1M Return-5.73%

Cash-MV

Value0.03

Score1/3

Weight10.58%

1M Return-3.56%

Net profit / Total profit (%)

Value100.00

Score1/3

Weight7.45%

1M Return-2.37%

Is ICCM fundamentally strong?

ICCM scores 0.88/10 on fundamentals and holds a Premium valuation at present. Backed by its -188.78% ROE, -445.61% net margin, -2.96 P/E ratio, 4.93 P/B ratio, and 20.00% earnings growth, these metrics solidify its Underperform investment rating.